Welcome to the e-CCO Library!

OP006: Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn’s disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Strik1*, M. Löwenberg1, C. Ponsioen1, K. Gecse2, C. Buskens3, W. Bemelman3, G. D’Haens1

Created: Thursday, 21 February 2019, 9:14 AM
OP007: α4β7 Integrin-dependent gut homing of non-classical monocytes is essential for intestinal wound healing mediated by M2 macrophages
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Schleier1, M. Wiendl1, M.-T. Binder1, R. Atreya1, A. Watson2, C. Neufert1, I. Atreya1, M.F. Neurath1, S. Zundler1*

Created: Thursday, 21 February 2019, 9:14 AM
OP007: A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Lawrance I.
Last Modified: Wednesday, 15 March 2017, 2:21 PM by ECCO Administrator
Tacrolimus, Proctitis
Files: 1
OP007: A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lawrance I.C.*1,2, Baird A.1, Lightowler D.2, Radford-Smith G.3, Andrews J.M.4, Connor S.5

Created: Wednesday, 20 February 2019, 10:36 AM
OP007: Comprehensive epigenome-wide DNA methylation profiling in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

N. Ventham*1, N. Kennedy1, A. Adams1, R. Kalla1, S. Heath2, K. O’Leary1, H. Drummond1, D. Wilson3, T. IBD-BIOM Consortium1, T. IBD-CHARACTER Consortium1, I. Gut2, E. R. Nimmo1, J. Satsangi1

Created: Friday, 22 February 2019, 9:49 AM
OP007: Detection of mucosal healing with a serum marker panel in adalimumab treated patients with Ulcerative Colitis
Year: 2018
Source: ECCO'18 Vienna
Authors: de Bruyn Magali
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
OP008: An innovative treatment for refractory perianal fistulas in Crohn's disease: local micro reinjection of autologous fat and adipose derived stromal vascular fraction
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Serrero M.*1, Philandrianos C.2, Visee C.3, Veran J.2, Orsoni P.3, Sabatier F.2, Grimaud J.-C.1

Created: Wednesday, 20 February 2019, 10:36 AM
OP008: An innovative treatment for refractory perianal fistulas in Crohn’s Disease: Local micro reinjection of autologous fat and adipose derived stromal vascular fraction (ClinicalTrials. gov NCT02520843, Eudract: 2013-002602-31)
Year: 2017
Source: ECCO'17 Barcelona
Authors: Serrero M.
Last Modified: Wednesday, 15 March 2017, 2:24 PM by ECCO Administrator
Perenial fistulae, Perianal disease, Autologous stem cell transplantation
Files: 1
OP008: Detection of mucosal healing with a serum marker panel in adalimumab-treated patients with ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. de Bruyn1,2*, R. Ringold3, E. Martens2, M. Ferrante1,4, G. Van Assche1,4, G. Opdenakker2, A. Dukler3, S. Vermeire1,4

Created: Thursday, 21 February 2019, 9:14 AM
OP008: Genotype-phenotype analysis across 130 422 genetic variants identifies RSPO3 as the first genome-wide significant modifier gene in primary sclerosing cholangitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

R. Alberts*1, E. M. de Vries2, G. Alexander3, D. Alvaro4, A. Bergquist5, U. Beuers2, E. Björnsson6, K. M. Boberg7, C. L. Bowlus8, R. W. Chapman9, O. Chazouillères10, A. Cheung11, G. Dalekos12, B. Eksteen13, D. Ellinghaus14, M. Färkkilä15, E. A. Festen1, A. Floreani16, T. Folseraas7, E. Goode17, D. N. Gotthardt18, G. M. Hirschfield19, B. van Hoek20, K. Holm7, S. Hohenester21, J. R. Hov7, F. Imhann1, P. Invernizzi22, X. Jiang7, J. Eaton23, B. D. Juran24, K. N. Lazaridis24, V. Leppa25, J. Z. Liu26, J. Löfberg27, M. P. Manns28, H.-U. Marschall29, M. Marzioni30, A. L. Mason31, E. Melum7, P. Milkiewicz32, T. Müller33, A. Pares34, C. Rupp35, S. M. Rushbrook36, C. Rust37, F. Sampaziotis38, R. N. Sandford39, C. Schramm40, S. Schreiber14, E. Schrumpf7, M. Silverberg41, B. Srivastava39, M. Sterneck42, A. Teufel43, L. Tittmann44, L. Vallier38, A. V. Vila1, B. de Vries1, T. J. Weismüller28, C. Wijmenga45, K. Zachou46, A. Franke14, C. A. Anderson47, T. H. Karlsen7, C. Y. Ponsioen2, R. K. Weersma1

Created: Friday, 22 February 2019, 9:49 AM
OP009: A combination of clinical, serological, and genetic factors predicts complicated disease course in paediatric-onset Crohn’s disease: results from a population-based study
Year: 2018
Source: ECCO '18 Vienna
Authors:

H. Sarter1,2*, G. Savoye3, D. Turck2,4, F. Vasseur5, G. Marot6,7, B. Pariente2,8, S. Singh9, J.F. Colombel10, C. Gower-Rousseau1,2, M. Fumery11

Created: Thursday, 21 February 2019, 9:14 AM
OP009: Gene-microbiome interactions underlying the onset and the clinical phenotypes of inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

F. Imhann*1, A. Vich Vila1, M. J. Bonder2, D. Gevers3, J. Fu2, M. C. Visschedijk1, L.M. Spekhorst1, L. Franke2, H. van Dullemen1, R. W. F. Ter Steege1, C. Huttenhower4, G. Dijkstra1, R. J. Xavier3, C. Wijmenga2, E. A. M. Festen1, A. Zhernakova2, R. K. Weersma1

Created: Friday, 22 February 2019, 9:49 AM
OP009: Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn's disease: 52-week results of a phase III randomised controlled trial
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Panes J.*1, García-Olmo D.2, Van Assche G.3, Colombel J.-F.4, Reinisch W.5, Baumgart D.C.6, Nachury M.7, Ferrante M.3, Kazemi-Shirazi L.5, Grimaud J.C.8, de la Portilla F.9, Goldin E.10, Richard M.P.11, Diez M.C.11, Danese S.12

Created: Wednesday, 20 February 2019, 10:36 AM
OP009: Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn’s Disease: 52-week results of a phase III randomised controlled trial
Year: 2017
Source: ECCO'17 Barcelona
Authors: Panés J.
Last Modified: Wednesday, 15 March 2017, 2:43 PM by ECCO Administrator
Stem cell transplantation/therapy
Files: 1
OP01 Higher vs. standard adalimumab maintenance regimens in patients with moderately to severely active ulcerative colitis: Results from the SERENE-UC maintenance study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.F. Colombel1, J. Panés2, G. D’Haens3, S. Schreiber4, R. Panaccione5, L. Peyrin-Biroulet6, E.V. Loftus Jr7, S. Danese8, E. Louis9, A. Armuzzi10, M. Ferrante11, H. Vogelsang12, J. Lefebvre13, T. Doan14, W. Xie15, B. Huang15, J. Petersson16, J. Kalabic17, A. Robinson18, W.J. Sandborn19

Created: Thursday, 30 January 2020, 10:12 AM
OP010: Azathioprine dose reduction in patients with inflammatory bowel disease on combination therapy: a prospective study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

E. Del Tedesco1, S. Paul2, H. Marotte3, C. Jarlot1, N. Williet4, J. M. Phelip4, L. Peyrin Biroulet5, J. F. Colombel6, X. Roblin*4

Created: Friday, 22 February 2019, 9:49 AM
OP010: Long term efficacy and safety of Ustekinumab for Crohn's disease: results from IM-UNITI long-term extension through 2 years
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sandborn W.1, Rutgeerts P.2, Gasink C.3, Jacobstein D.3, Gao L.-L.3, Johanns J.3, Sands B.4, Hanauer S.B.5, Targan S.6, Ghosh S.7, de Villiers W.J.S8, Colombel J.-F.4, Feagan B.G.*9

Created: Wednesday, 20 February 2019, 10:36 AM
OP010: Long term efficacy and safety of Ustekinumab for Crohn’s Disease: Results from IM-UNITI long-term extension through 2 years
Year: 2017
Source: ECCO'17 Barcelona
Authors: Feagan B.
Last Modified: Wednesday, 15 March 2017, 2:45 PM by ECCO Administrator
Ustekinumab
Files: 1
OP010: Shallow whole genome sequencing predicts the future cancer risk of low grade dysplastic lesions arising in Ulcerative Colitis
Year: 2018
Source: ECCO'18 Vienna
Authors: Al Bakir Ibrahim
Created: Friday, 23 March 2018, 12:23 PM
Files: 1